Results 71 to 80 of about 61,930 (311)

Onasemnogene Abeparvovec in Type I Spinal Muscular Atrophy: 24‐Month Follow‐Up From the Italian Registry

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane   +43 more
wiley   +1 more source

Assist scholarships.

open access: yes, 1988
Scholarships to visit America won by three girls.

core  

Effects of long term feeding dairy cows on a diet supplemented with clinoptilolite on certain haematological parameters

open access: yesVeterinární Medicína, 2005
The effect of the dietary inclusion of clinoptilolite on the haematological parameters of dairy cows has not been studied yet; however in mice, prolonged zeolite administration causes disturbances in the adaptation of erythropoiesis in periods of ...
P.D. Katsoulos   +5 more
doaj   +1 more source

Peripheral Neutrophil Activation and Extracellular Trap Formation in Amyotrophic Lateral Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
Markers of neutrophil activation are increased in plasma during ALS, and markers of NET formation associate with ALS survival. ABSTRACT Objectives Peripheral neutrophil levels in amyotrophic lateral sclerosis (ALS) inversely correlate with survival, suggesting a role for neutrophils in disease progression.
Lillia A. Baird   +9 more
wiley   +1 more source

Images from the Pathways and Vocational Education, Scholarships and Prizes Ceremony, 4th April 2019

open access: yes, 2019
Complete set of images from the Pathways and Vocational Education Scholarships and Prizes Ceremony 2019.
University Advancement
core  

Onasemnogene Abeparvovec in Patients With SMA: Interim Results of the RESTORE Registry in Japan

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective There are limited real‐world data regarding the safety and effectiveness of onasemnogene abeparvovec (OA; Zolgensma) infusion, a one‐time gene replacement therapy, for Japanese patients with spinal muscular atrophy (SMA). We aimed to improve understanding of the real‐world outcomes for OA in Japan.
Kayoko Saito   +8 more
wiley   +1 more source

Images from the Faculty of Business and Law, Scholarships and Prizes Ceremony 2019

open access: yes, 2019
Complete set of images from the 2019 Faculty of Business and Law, Scholarships and Prizes Ceremony.
University Advancement
core  

The politics of scholarly exchange: Taking the long view on the rhodes scholarships [PDF]

open access: yes, 2023
This chapter is the first attempt at a general historical analysis of the way in which the scholarship shaped the lives of those who received it. It takes a dual approach to the long view on scholarly exchange.
Pietsch, T, Chou, MH
core  

Awards and Scholarships

open access: yesHuman-Wildlife Interactions, 2017
Dr. Michael Kuhns, Department Head for Utah State University Wildland Resources (left) presents Dr. Michael R. Conover (right) with a U.S. Department of Agriculture (USDA) Special Recognition Award at a recent Department of Wildland Resources meeting at ...
Terry A. Messmer
doaj   +1 more source

Clinical and Modifiable Factors Associated With Disability and Relapse in MOGAD: A Multicentre Cohort Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Factors associated with relapse course and disability in myelin oligodendrocyte glycoprotein antibody‐associated disease (MOGAD) remain incompletely understood. Objectives To identify clinical and modifiable factors associated with relapse and disability in MOGAD. Methods In this ambispective multicentre cohort study using data from
Yingtao Wang   +23 more
wiley   +1 more source

Home - About - Disclaimer - Privacy